Remote Monitoring

Remote cardiac monitoring technologies enable patient health to be tracked outside the clinical setting. It can be used for longer term monitoring to help diagnosis arrhythmias or other cardiac conditions. Remote monitoring also can keep tabs on chronic conditions such as heart failure or hypertension and alert clinicians to worsening symptoms to avoid an acute care episode or hospitalization.

RSS icon
JR Finkelmeier PaceMate

PaceMate names former Philips, BioTelemetry leader its new chief commercial officer

JR Finkelmeier has more than 20 years of experience in the healthcare and medical device industries.

Dexcom, a global healthcare technology company based out of San Diego, has received U.S. Food and Drug Administration (FDA) clearance for Stelo, a wearable glucose biosensor that can be obtained without a prescription.

FDA clears first over-the-counter wearable device for continuous glucose monitoring

The newly cleared device is worn on the back of the arm and sends data directly to the user's smartphone. 

healthcare money economics dollar stethoscope acquire merger

Philips-owned BioTelemetry to pay nearly $15M for allegedly misleading clinicians to secure higher reimbursements

The company and one of its subsidiaries would allegedly confuse clinicians and have them bill government programs for cardiac monitoring services that were more expensive than what they needed. This settlement resolves those allegations. 

money business cash flow dollar

Holding company acquires heart monitoring specialists Digital Diagnostics Imaging for $11M

DDI currently has contracts with nursing homes and hospitals in 42 states.

mergers acquisitions puzzle M&A

Report: Private equity firm exploring deal worth more than $7B to acquire 2 Medtronic businesses

Carlyle Group, one of the world’s largest private equity firms, is reportedly working to buy the two business units and turn them into a brand new company. 

GE Healthcare's Portrait Mobile wireless and wearable monitoring solution

GE HealthCare earns FDA clearance for new remote patient monitoring device

The newly cleared device was designed with patient freedom and flexibility in mind. 

the words "FDA recall" on a board

Medtronic recalls nearly 350,000 implantable heart devices after 22 injuries

The FDA has categorized this as a Class I recall, meaning the use of these devices could cause “serious injuries or death.”

The proliferation of artificial intelligence (AI) in healthcare includes numerous algorithms for electrophysiology (EP). Jagmeet Singh, MD, Professor of Medicine, Harvard Medical School, and founding director of the Resynchronization and Advanced Cardiac Therapeutics Program and Mass General Hospital, spoke with Cardiovascular Business at Heart Rhythm 2023 to explain how AI is being used in EP. #HRS2023 #HRS #AI

AI gaining popularity in electrophysiology

There are now numerous AI algorithms for electrophysiology. Jagmeet Singh, MD, examined how this advanced technology is being applied.

Displaying 9 - 16 of 21

Around the web

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Design by Adaptive Theme
Trimed Popup
Trimed Popup